J.D., University of Maryland
M.S., Biology, University of Maryland
B.A., Biology, University of Maryland
United States Patent and Trademark Office
District of Columbia
United States Court of Appeals for the Federal Circuit
United States Supreme Court
Ms. Kim, a director in the Biotechnology/Chemical Group, counsels entities around the world on patent portfolio strategy and long-term corporate development. Her practice involves the preparation of patent applications and their prosecution and appeals worldwide, contested proceedings before the U.S. Patent and Trademark Office, and management of foreign oppositions to protect inventions and maximize market share. She provides opinions on invalidity and noninfringement to ensure freedom to operate. She also conducts due diligence for the evaluation of investments and acquisitions. For nearly 20 years, Ms. Kim has counseled entities innovating in technologies such as pharmaceuticals, biotechnology, immunology, biofuel, food products, and nutraceuticals.
Ms. Kim’s scientific experience is in the areas of microbial and mammalian biology. As a graduate student, she researched the regulation of the chloramphenicol acetyltransferase gene in Bacillus subtilis. She then worked as a research scientist studying the developmental expression of thyrotropin releasing hormone in mammalian systems. Ms. Kim is a co-author of eleven publications resulting from her scientific research.
Ms. Kim is an Adjunct Professor at Sogang University Law School in Korea. She was an editor of the Journal of International Law and Trade. She speaks conversational Korean.
Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.LL.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler. If you are not already a client of Sterne Kessler, do not include any confidential information in this message.